Asia Inexperienced Biotechnology Corp. Proclaims Submitting of Monetary Statements on SEDAR
[NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES]
CALGARY, AB / ACCESSWIRE / Might 24, 2024 / Asia Inexperienced Biotechnology Corp. (“Asia Inexperienced” or the “Firm”) (CSE:ASIA) proclaims that, additional to its information releases dated April 17, 2024, April 26, 2024, Might 8, 2024, and Might 10, 2024, the Firm has filed the next steady disclosure paperwork (collectively, the “Paperwork”) on SEDAR:
-
the Firm’s Annual Audited Monetary Statements for the yr ended December 31, 2023, as required by part 4.2 of Nationwide Instrument 51-102 – Steady Disclosure Obligations (“NI 51-102”); and
-
the Firm’s Administration Dialogue & Evaluation for the yr ended December 31, 2023, as required by part 5.1(2) of NI 51-102.
-
CEO and CFO certificates regarding the Audited Annual Monetary Statements, as required by NI 52-109.
It’s anticipated that the Administration Stop Commerce Order (“MCTO”) issued by the Alberta Securities Fee (“ASC”) on Might 8, 2024, will now be lifted.
As well as, the Firm additionally introduced in the present day that Vincent Ghazar has resigned from his positions as Chief Monetary Officer and Director of the Firm. Mr. Ghazar will stay with the Firm as a marketing consultant offering accountancy companies within the close to time period.
For additional info, contact:
Asia Inexperienced Biotechnology Corp.
David Pinkman (CEO)
T: 403 863-6034
E: david.pinkman@asiagreenbiotechnology.com
Neither TSX Enterprise Trade nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Trade) accepts accountability for the adequacy or accuracy of this launch.
SOURCE: Asia Inexperienced Biotechnology Corp.
View the unique press launch on accesswire.com
